Effects of Tamoxifen on Periodontal Disease and Candida Albicans of Patients with Breast Cancer and Other Pathologies

References

• Reynaud AH , Nygaard-OstbyB , BoygardGKet al. Yeasts in periodontal pockets . J. Clin. Periodontol.28 ( 9 ), 860 – 864 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Jewtuchowicz VM , MujicaMT , BruscaMIet al. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina . Oral Microbiol. Inmunol.23 ( 6 ), 505 – 509 ( 2008 ).
   PubMedGoogle Scholar
• Rubio NA , PuiaS , ToranzoSet al. Invasión fúngica en tejido conectivo en pacientes con enfermedad gingivo-periodontal . Rev. Iberoam. Micol.32 ( 1 ), 20 – 24 ( 2015 ).
   PubMedGoogle Scholar
• Cuesta AI , JewtuchowiczV , BruscaMIet al. Prevalence of Staphylococcus spp and Candida spp in the oral cavity and periodontal pockets of periodontal disease patients . Acta Odontol. Latinoam.23 ( 1 ), 20 – 26 ( 2010 ).
   PubMedGoogle Scholar
• Shafiro LF , FreemanK . The relationship between estrogens, estrogens receptors and periodontal disease in adult women: a review of the literature . NY State Den. J.80 ( 3 ), 30 – 34 ( 2014 ).
   PubMedGoogle Scholar
• Brusca MI , RosaA , AlbainaOet al. The impact of oral contraceptives on women‘s periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species . J. Periodontol.81 ( 7 ), 1010 – 1018 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Brusca MI , VerdugoF , AmighiniCet al. Anabolic steroids affect human periodontal health and microbiota . Clin. Oral Investig.18 ( 6 ), 1579 – 1586 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kevin E , LevinR , ActisA . Clave en el tratamiento del cáncer de mama . LevinE( Ed. ) . Fundación oncológica Encuentro , Buenos Aires, Argentina , 71 ( 2003 ).
   Google Scholar
• Beggs WH . Anti-Candida activity of the anti-cancer drug tamoxifen . Res. Commun. Chem. Pathol. Pharmacol.80 ( 1 ), 125 – 128 ( 1993 ).
   PubMedGoogle Scholar
• Beggs WH . Growth phase in relation to the lethal acción of tamoxifen on Candida albicans . Res. Commun. Mol. Pathol. Pharmacol.88 ( 1 ), 115 – 118 ( 1995 ).
   PubMedGoogle Scholar
• Dolan K , MontgomeryS , BuckheitBet al. Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization . Antimicrob. Agents Chemother.53 ( 8 ), 3337 – 3346 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Routh MM , RautJS , KaruppayilSM . Dual properties of anticancer agents: an exploratory study on the in vitro anti-Candida properties of thirty drugs . Chemotherapy57 ( 5 ), 372 – 380 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Routh MM , RajputSB , RautJSet al. Anticancer drugs as enhancers of fluconazole sensitivity in Candida albicans . Afr. J. Microbiol. Res.7 ( 14 ), 1253 – 1261 ( 2013 ).
   Google Scholar
• Routh MM , ChauhanNM , RajputSBet al. Cancer drugs inhibit germ tube elongation in Candida albicans . JSRR3 ( 1 ), 97 – 109 ( 2014 ).
   Google Scholar
• Wakharde AA , HalbandgeSD , PhuleDBet al. Anticancer drugs as antibiofilm agents in Candida albicans: potential targets . Assay Drug Dev. Technol.16 ( 5 ), 232 – 246 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Cornely OA , MaertensJ , WinstonDJet al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia . N. Engl. J. Med.356 ( 4 ), 348 – 359 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Passero P , BarceloS , BálsamoFet al. El tamoxifeno inhibe el crecimiento de Candida albicans resistente a azoles. Presented at: IX International Symposium on Natural Products Chemistry and Applications . Termas de Chillán, Chile , 22–25 November 2016 .
   Google Scholar
• White T , HollemanS , DyFet al. Resistance mechanisms in clinical isolates of Candida albicans . Antimicrob. Agents Chemother.46 ( 6 ), 1704 – 1713 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Clínical and Laboratory Standards Institute . Reference method for broth dilution. Antifungal susceptibility testing of yeasts . Approved standard M27-A3; 3rd Edition . Clínical and Laboratory Standards Institute , PA, USA ( 2008 ).
   Google Scholar
• Barceló S , PeraltaM , CaliseMet al. Interactions of a prenylated flavonoid from Dalea elegans with fluconazole against azole-resistant Candida albicans . Phytomedicine32 , 24 – 29 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Machado AG , Yukio KomiyamaE , Soléo Ferreira dos SantosSet al. In vitro adherence of Candida albicans isolated from patients with chronic periodontitis . J. Appl. Oral Sci.19 ( 4 ), 384 – 387 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Peters BA , WuJ , HayesRBet al. The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study . BMC Microbiol.17 ( 1 ), 157 ( 2017 ) .
   PubMedGoogle Scholar
• Peralta MA , CaliseM , FornariMCet al. A prenylated flavanone from Dalea elegans inhibits rhodamine 6G efflux and reverses fluconazole resistance in Candida albicans . Planta Med.78 ( 10 ), 981 – 987 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• White TC , PfallerMA , RinaldiMGet al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient . Oral Dis.3 ( 1 ), 102 – 109 ( 1997 ).
   Google Scholar
• Muthular M , PasseroP , BálsamoFet al. Inhibitory effect of diethylstilbestrol on clinical strains of Candida albicans (in review in Rev. Iberoam. Micol.) . Rev. Iberoam. Micol. ( In Press )
   Google Scholar
• Pérez C , TiraboschiIN , OrtegaMGet al. Further antimicrobial studies of 2′,4′-dihidroxy-5′-(1′′′-1′′′-dimethylaleye)-6-prenylpinocembrin from Dalea elegans . Pharm. Biol.41 ( 3 ), 171 ( 2003 ).
   Web of Science ®Google Scholar
• Elingold I , IsollabellaMP , CasanovaMet al. Mithocondrial toxicity and antioxidant activity of a prenylated flavonoid isolated from Dalea elegans . Chem. Biol. Interact.171 ( 3 ), 294 – 305 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kisanga ER , GjerdeJ , Guerrieri-GonzagaAet al. Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial . Clin. Cancer Res.10 , 2336 – 2343 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Soory M , TilakaratneA . Modulation of androgen metabolism by phenytoin, oestradiol and tamoxifen in human gingival fibroblasts . J. Clin. Periodontol.30 , 556 – 561 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Safdar A , ArmstrongD . Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short term survival in recipients of marrow transplantation and patients with hematological malignancies . Bone Marrow Transplant.30 , 931 – 935 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Trinconi CT , ReimãoJQ , BonanoVIet al. Topical tamoxifen in the therapy of cutaneous leishmaniasis . Parasitology145 ( 4 ), 490 – 496 ( 2018 ).
   PubMed Web of Science ®Google Scholar